Bengaluru: Biocon chairperson Kiran Mazumdar-Shaw on Monday night said she tested COVID-19 positive."I have added to the COVID count by t...Read More
New Delhi: Shares of biotechnology major Biocon on Friday dropped nearly 4 per cent after the company reported a 26.30 per cent decline i...Read More
By FPJ Web Desk
Biocon’s subsidiary Biocon Biologics has received Drugs Controller General of India’s (DCGI) approval to use CytoSorb to treat critical C...Read More
The company had posted a net profit of Rs 214 crore for the corresponding period of the previous fiscal, Biocon said in a statement.
Biocon Ltd. and Mylan N V on Tuesday announced the launch of Fulphila, a biosimilar to Neulasta (pegfilgrastim), in Australia.
The company had posted a net profit of Rs 217.2 crore for the corresponding period of the previous fiscal, Biocon said.
New Delhi: Pharmaceuticals major Biocon Ltd on Monday said that its subsidiary Biocon Biologics India has approved the acquisition of 2.4...Read More
By Rupesh Shetty
Mazumdar Shaw, who is also a chairman of Biocon, was alleged to have violated provisions of the Prohibition of Insider Trading (PIT) regu...Read More
New Delhi: Biotechnology major Biocon reported a net profit of Rs 215.7 crore for the quarter ended September 30, 2019.The company had p...Read More
On Thursday Finance Minister Nirmala Sitharaman had defended her decision to ban e-cigarettes after Biocon chief Kiran Mazumdar-Shaw ques...Read More
Reminds Biocon chief of govt's fiscal steps on growth revival
Biocon reported a 72.34 per cent rise in consolidated net profit to Rs 206.3 crore for the quarter ended on June 30, 2019 mainly on accou...Read More
"The inspection across these three units concluded with 12 observations issued on the Form 483"
New Delhi: Biotechnology major Biocon on Wednesday said the European Commission has approved and granted marketing authorisation to its b...Read More
Hyderabad : India may have created a competitive market by abolishing licence raj, but it has been replaced by an equally time-consuming ...Read More
New Delhi : Biocon branded formulations business announced the launch of a new patient support program ‘Ek Prayaas’ through a nationwide ...Read More
By FPJ Bureau
Bengaluru : The Karnataka government on Wednesday approved three projects, including that of PepsiCo India and Biocon, committing total i...Read More
New Delhi: Biocon has received approval from the Japanese health authority to sell its biosimilar product ‘Insulin Glargine’ in that coun...Read More
New Delhi: In a typical example of the government’s one arm not knowing what other arm is doing, the Health Ministry has been taken aback...Read More
After 18 months of eye-ball-to-eye-ball confrontation in Parliament, the BJP and the Congress have realised that hubris and negativism wi...Read More